Chih-ming Chen
Chairman
Pharmaceuticals
TWi Biotechnology
Taiwan
Biography
Dr. Chih-Ming Chen has served as the chairman of the board since the inception of the company. In 1993, Dr. Chen co-founded Andrx Corporation in Florida, USA. Under his leadership, Andrx filed several significant ANDA's of controlled-release (CR) oral dosage forms, primarily with PIV applications. He and his team obtained over 50 patents and more than 20 ANDA approvals of mostly CR products in US. In 2002, Dr. Chen founded his second company, Anchen Pharmaceuticals in Irvine, California, with its initial R&D labs in Taiwan, which was spun off and went public on the Taipei Exchange in 2013. Dr. Chen brings his experience in R&D technology of various dosage forms and his business acumen to TWi Biotechnology and continues to focus on producing innovative and niche products. Dr. Chen received his Ph.D. in Pharmacy from Ohio State University and B.S./M.S. degrees in Pharmacy from National Taiwan University.
Research Interest
Toxicology
